Rare
lephants
Screener
Toggle theme
AccuStem Sciences, Inc.
ACUT
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Book Per Share
Compare
←
5Y
10Y
MAX
→
Book Per Share
Chart
Table
Fiscal Year
Book Per Share
FY2022
$-0.01
FY2023
$-0.19
FY2024
$-0.29
FY2025
$-0.22
Download CSV
